Cell Based Screening in Drug Discovery 2022
Poster
25

Application of Attana Cell-based QCM Interaction studies in Drug Discovery

Abstract

Attana’s proprietary QCM-based biosensor technology enables label-free real-time analysis of biomolecular interactions in a biologically relevant environment. The technology can shed light on interactions between biomolecules and cells or tissue and perform assays with crude samples and in sera. With the therapeutical targets present in their natural cellular environment, target validation can be performed closer to in vivo conditions.

In this overview we present cellular interaction studies with focus on target validation, glycosylation profile, competitive QCM, and off-target interactions.

supporting document

There is an invitation to view a presentation here - register and login to view

Hosted By

ELRIG

The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis

Get the App

Get this event information on your mobile by
going to the Apple or Google Store and search for 'myEventflo'
iPhone App
Android App
www.myeventflo.com/2419